Ancalima Lifesciences Limited - Company Profile

Q: Who are the current directors of Ancalima Lifesciences Limited?

The current directors of Ancalima Lifesciences Limited are Sandeep Sharma, Sakshi Garg, Rajeev Garg.

It is a pharma public limited company based in Sonipat, Haryana, India, established in 1988.

1988 Sonipat, Haryana, India Active

Last Updated: February 17, 2026

About Ancalima Lifesciences Limited

Ancalima Lifesciences Limited, a active public limited company, was established on 02 May 1988 in Sonipat, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U52110HR1988PLC135948. Registered under ROC Roc Haryana. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.

Formerly known as Uni Sule Laboratories Pvt Ltd, Pfiscar India Limited. It upholds a compliant status. Employing 51 professional, Its leadership includes Sandeep Sharma (Director), Sakshi Garg (Director), Rajeev Garg (Director). Past directors included Sita Ram Garg, Sakshi Garg, Vishal Singla. It holds ₹9.56 Cr open charges and ₹16.78 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 50Th Km Stone,, National Highway No. 44, Murthal, Sonipat, Haryana, 131039.

Company Details

CIN/LLPIN
U52110HR1988PLC135948
Registration Number
135948
Incorporation Date
02 May 1988
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹1.00 Cr
ROC Code
Roc Haryana
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 17-02-2026
Paid Up Capital ₹ 1.00 Cr as on 17-02-2026
Company Age 37 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 9.56 Cr as on 17-02-2026
Satisfied Charges ₹ 16.78 Cr as on 17-02-2026

Comprehensive Company Insights

Explore comprehensive insights into Ancalima Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ancalima Lifesciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sandeep Sharma	Director	01 Apr 2019	Current
Sakshi Garg	Director	01 Jul 2024	Current
Rajeev Garg	Director	15 Feb 1996	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Jul 2024	Past
Pramod Abcsdd	Director	01 Apr 2019	Past
Pramod Abcsdd	Director	02 Nov 2009	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ancalima Lifesciences.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ancalima Lifesciences?

Unlock access to Ancalima Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹95,575,000.00

Satisfied Charges

₹167,823,508.50

Charges Breakdown by Lending Institutions

Others : 9.40 Cr
Canara Bank : 0.16 Cr

Latest Charge Details

Date	Lender	Amount	Status
07 Jan 2026	Others	₹4.90 Cr	Open
04 Feb 2025	Others	₹4.50 Cr	Open
09 May 2024	Canara Bank	₹1.58 M	Open
28 Sep 2022	Canara Bank	₹5.68 Cr	Satisfied
01 Feb 2022	Others	₹3.17 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ancalima Lifesciences?

Unlock and access historical data on people associated with Ancalima Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ancalima Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ancalima Lifesciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ancalima Lifesciences

Recent Activity within the Organization

Charges

Progress on A charge with Others amounted to Rs. 4.90 Cr with Charge ID 101230863 was registered on 07 Jan 2026. was documented.
07 Jan 2026
Annual General Meeting

The activity Ancalima Lifesciences Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

Progress on Ancalima Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana. was documented.
31 Mar 2025
Charges

A charge with Others of Rs. 4.50 Cr registered on 04 Feb 2025 with Charge ID 101069934 was modified on 07 Mar 2025. was recorded as a recent event.
07 Mar 2025
Charges

The activity A charge registered on 28 Sep 2022 via Charge ID 100620785 with Canara Bank was fully satisfied on 24 Feb 2025. was completed.
24 Feb 2025
Charges

Progress on A charge with Others amounted to Rs. 4.50 Cr with Charge ID 101069934 was registered on 04 Feb 2025. was documented.
04 Feb 2025

Explore recent activity and updates - View Recent Activity